Aluminum Chloride Or Bromide Patents (Class 424/685)
-
Publication number: 20140348921Abstract: The present invention relates to a novel hemostatic composition notably useful to ensure good hemostasis and maintain the sulcular opening after a gingival eviction procedure. According to the invention, this composition is in the form of an extrudable hydrophilic paste and contains, expressed as percentage by weight relative to the total weight of said composition: between 5 and 15% of an astringent, preferably aluminum chloride; between 2 and 15% of kaolinitic clay, preferably kaolin; between 10 and 20% of a texturizing agent comprising one (or more) naturally-occurring polysaccharide(s) with gelling or thickening power optionally combined with plant fibers; between 50 and 70% of water; between 0 and 20% of a humectant; the total quantity of water and humectant being comprised between 55 and 75% by weight relative to the total weight of the composition.Type: ApplicationFiled: July 18, 2012Publication date: November 27, 2014Inventor: Patrick Lesage
-
Publication number: 20140248270Abstract: A method of treating a tar-responsive dermatological disorder includes topically applying an anhydrous tar composition to skin of a mammal, preferably a human, that is involved with the disorder, the composition including a wax and a therapeutically effective amount of tar for topical treatment of the tar-responsive dermatological disorder, the composition being in liquid form when at a temperature selected from room temperature and a temperature of skin of a mammal upon application of the composition to the skin of the mammal.Type: ApplicationFiled: May 13, 2014Publication date: September 4, 2014Inventors: Ruey J. YU, Eugene J. VAN SCOTT
-
Patent number: 8703104Abstract: A system and method for treating hoof related diseases, particularly hairy heel warts (papillomatus digital dermatitis), includes an aqueous solution having a metal astringent at a therapeutically effective concentration. The metal astringent includes aluminum, iron, and mixtures thereof. In preferred embodiments, the metal may include a mixture of monomeric and polymeric species. The polymeric species may be in the form of a polymeric concentrate, such as, for example, polyaluminum chloride or polyferric sulfate. Alternatively, the polymeric species may be formed by partially neutralizing a metal salt. The aqueous solution of the metal astringent is applied to a lower leg and hoof area of an animal using any known application technique, including, but not limited to, foot baths, foams and spray applications. In preferred embodiments, the aqueous solution is applied using an automated dispensing system.Type: GrantFiled: October 25, 2007Date of Patent: April 22, 2014Assignee: Ecolab USA IncInventors: Joseph P. Morelli, Jeffrey R. Fernandes, Edward L. C. Verkaar, Petra Vogt
-
Patent number: 8658193Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.Type: GrantFiled: June 8, 2012Date of Patent: February 25, 2014Inventor: Robert J. Greenwald
-
Publication number: 20130330416Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.Type: ApplicationFiled: June 8, 2012Publication date: December 12, 2013Inventor: Robert J. Greenwald
-
Publication number: 20130129637Abstract: The present invention provides a kit or article of manufacture comprising as separate components: (a) a polymeric metal astringent; (b) an anionic surfactant; wherein combining component (a) and (b) provides a reaction product of said polymeric metal astringent and said anionic surfactant in form of a precipitate comprising said metal astringent and said anionic surfactant, for use in the preventive and/or therapeutic treatment of hoof or foot disease in cattle and other types of hoofed animals.Type: ApplicationFiled: January 15, 2010Publication date: May 23, 2013Applicant: ECOLAB USA INC.Inventors: Iris C. Beckert, Petra Vogt
-
Publication number: 20120253298Abstract: A tissue thickness compensator may generally comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a third layer comprising a third medicament. The tissue thickness compensator may comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a reservoir comprising a third medicament disposed within the reservoir. The medicaments may be independently selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof. Articles of manufacture comprising the tissue thickness compensator and methods of making and using the tissue thickness compensator are also described.Type: ApplicationFiled: March 28, 2012Publication date: October 4, 2012Applicant: Ethicon Endo-Surgery, Inc.Inventors: Cortney E. Henderson, Taylor W. Aronhalt, Chunlin Yang, Charles J. Scheib, Venkataramanan Mandakolathur Vasudevan, Mark D. Timmer, Richard W. Timm, Tamara Widenhouse, Steven G. Hall
-
Publication number: 20120164239Abstract: A composition for treating wood-based material including at least one C1-C7 monocarboxylic acid salt or C1-C7 monocarboxylic acid or a mixture thereof as active agent against deteriation of wood. The composition also includes alkyd emulsion of high unsaturated fatty acid content and/or aluminum ion containing compound in the form of polyaluminum formate in a same aqueous liquid carrier as the C1-C7 monocarboxylic acid salt or C1-C7 monocarboxylic acid or a mixture thereof.Type: ApplicationFiled: November 25, 2009Publication date: June 28, 2012Inventors: Juha Estakari, Toivo Mertaniemi, Jari Jussila, Juha Kuusisto, Reijo Saunamäki, Norberto Mancuso
-
Patent number: 8197858Abstract: Novel etiology underlying certain types of seizures and migraines is presented, whereby changes in endocrine levels result in changes in osteoclast activity levels which in turn result in elevated extracellular Ca2+ levels which in turn result in systemic alterations in nerves muscles, including increased nerve membrane depolarization, enhanced calcium channel mediated neurotransmitter release, and increased muscle contractility via sarcoplasmic reticulum calcium release channel mediated tropomyosin block removal, which in turn result in increased seizure risk in people with low seizure thresholds. Treatment methods are provided that modulate the bone microenvironment to provide an etiology based seizure treatment method that simultaneously reduces nerve sensitivity and muscle contractility. Preferred embodiments include use of SERMs such as raloxifene, testosterone, estrogen, calcimimetics such as cinacalcet, RANKL inhibitors such as denosumab, and bisphosphonate such as risedronate.Type: GrantFiled: February 6, 2009Date of Patent: June 12, 2012Inventor: Mark John Zamoyski
-
Patent number: 8124059Abstract: The present invention describes a method and compositions by which introducing PO4?3 ion at particular stage in the preparation of aluminum/zirconium solutions surprisingly results in significantly improved zirconium molecular weight stability.Type: GrantFiled: February 22, 2010Date of Patent: February 28, 2012Assignee: Summit Research Labs, Inc.Inventors: Thomas L. Harper, Allan Rosenberg, Shailesh Mehta
-
Publication number: 20120027832Abstract: A molluscicidal composition, comprising: a molluscicide; a molluscicidal activity promoting additive comprising a calcium-containing salt of ethylene disuccinic acid or calcium ions and ethylenediamine disuccinic moieties, having at least 1 mole of calcium per mole of ethylenediamine disuccinic acid; and a carrier material edible to molluscs.Type: ApplicationFiled: January 26, 2010Publication date: February 2, 2012Inventors: Nicholas John Dixon, Derek Bassett, Reinhard Arndt, Andreas Prokop, Diana Parker, Tianye Chen
-
Publication number: 20110212157Abstract: The present invention describes systems and methods for treating disorders and/or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, and/or actinic keratosis. Methods generally involve administering nanoemulsions (e.g., nanoparticle compositions) comprising at least one therapeutic agent, such as botulinum toxin. In some embodiments, nanoemulsions are prepared, e.g., by high pressure microfluidization, and comprise a particle size distribution exclusively between 10 nm and 300 nm.Type: ApplicationFiled: June 26, 2009Publication date: September 1, 2011Applicant: ANTERIOS, INC.Inventors: Jonathan Edelson, Timothy Kotyla, Boke Zhang
-
Patent number: 7985209Abstract: A wound or surgical dressing is disclosed. The wound or surgical dressing is configured to cover or surround a wound, a surgical incision, or any type of skin irritation. In accordance with the present disclosure, the wound or surgical dressing is treated with a bacteriostatic composition that is capable of binding and trapping negatively charged matter, such as bacteria, pathogens, and the like. The bacteriostatic composition comprises a cationic polymer, a cationic oligomer, or particles coated with a cationic material. The bacteriostatic composition is bonded to the wound or surgical dressing in a manner such that the bacteriostatic composition is not substantially transferred to a patient being treated.Type: GrantFiled: December 15, 2005Date of Patent: July 26, 2011Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Julie M. Villanueva, Curtis Neil Sayre, Lei Huang, Kevin Peter McGrath, Ning Wei
-
Publication number: 20100247463Abstract: The present invention relates to an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof, the N-(phosphonoalkyl)-amino acid, related compound or derivative thereof being in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, other than N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine. Also included is a composition including an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, and a cosmetically or pharmaceutically acceptable vehicle for topical or systemic administration to a mammalian subject, as well as a method of administering an effective amount of such a composition for alleviating or improving a condition, disorder, symptom or syndrome associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system.Type: ApplicationFiled: June 16, 2010Publication date: September 30, 2010Inventors: Ruey J. Yu, Eugene J. Van Scott
-
Publication number: 20100215775Abstract: The invention relates to the use of C10-C14-alkane-1,2-diols, in particular 1,2-decanediol, 1,2-dodecanediol and/or 1,2-tetradecanediol, in the preparation of a composition for the prophylaxis and/or treatment of Malassezia-induced dandruff formation, as well as to cosmetic and/or dermatological preparations comprising C10-C14-alkane-1,2-diols.Type: ApplicationFiled: October 12, 2007Publication date: August 26, 2010Applicant: SYMRISE GmbH & Co. KGInventors: Gerhard Schmaus, Sabine Lange
-
Patent number: 7731943Abstract: The present invention describes a method and compositions by which introducing PO4?3 ion at particular stage in the preparation of aluminum/zirconium solutions surprisingly results in significantly improved zirconium molecular weight stability.Type: GrantFiled: May 13, 2005Date of Patent: June 8, 2010Assignee: Summit Research Labs, Inc.Inventors: Thomas L. Harper, Allan Rosenberg, Shailesh Mehta
-
Patent number: 7611695Abstract: Hemostatic compositions and dental etching compositions for oral use include methyl salicylate in order to mask or disguise their otherwise unpleasant taste. The methyl salicylate, hemostatic and/or dental etching agent are dispersed within an aqueous carrier, which may be liquid or viscous as desired. In order to increase the stickiness and the viscosity of the carrier, a higher molecular weight polyol and/or a finely divided inorganic filler may be included. Methyl salicylate is selected as the flavorant because it has been found to have enhanced stability in the presence of strongly acidic compositions compared to other flavorants known in the art. In addition, methyl salicylate does not leave behind an unpleasant after taste. For this reason, methyl salicylate is uniquely suited for masking or disguising the profoundly sour, bitter and rusty taste of hemostatic agents or the sour or bitter taste of dental etching agents.Type: GrantFiled: November 15, 2004Date of Patent: November 3, 2009Assignee: Ultradent Products, Inc.Inventor: Peter M. Allred
-
Publication number: 20090246280Abstract: An aluminum salt-containing resin powder of the present invention includes: at lest one matrix resin component selected from regenerated collagen, polyvinyl alcohol and carboxymethyl cellulose; and an aluminum salt. The aluminum salt is chemically bonded to the matrix resin component, and the resultant is powdered. A resin composition of the present invention includes 0.1 wt % or more and 80 wt % or less of the aluminum salt-containing resin powder and 20 wt % or more and 99.9 wt % or less of a resin other than the aluminum salt-containing resin. Thus, the present invention provides an aluminum salt-containing resin powder having a high phosphorus adsorption property, a high antibacterial property and a high antifungal property, and a resin composition containing the aluminum salt-containing resin powder.Type: ApplicationFiled: May 30, 2007Publication date: October 1, 2009Applicant: Kaneka CorporationInventor: Kenji Yamashita
-
Publication number: 20090110645Abstract: A system and method for treating hoof related diseases, particularly hairy heel warts (papillomatus digital dermatitis), includes an aqueous solution having a metal astringent at a therapeutically effective concentration. The metal astringent includes aluminum, iron, and mixtures thereof. In preferred embodiments, the metal may include a mixture of monomeric and polymeric species. The polymeric species may be in the form of a polymeric concentrate, such as, for example, polyaluminum chloride or polyferric sulfate. Alternatively, the polymeric species may be formed by partially neutralizing a metal salt. The aqueous solution of the metal astringent is applied to a lower leg and hoof area of an animal using any known application technique, including, but not limited to, foot baths, foams and spray applications. In preferred embodiments, the aqueous solution is applied using an automated dispensing system.Type: ApplicationFiled: October 25, 2007Publication date: April 30, 2009Applicant: Ecolab, Inc.Inventors: Joseph P. Morelli, Jeffrey R. Fernandes
-
Publication number: 20090041858Abstract: The present invention is the development of haemostatic compositions that use nitrogen containing organic polymers in combination with haemostatic agents to create a gel form. Compositions utilizing the polymers exhibit relatively lower concentrations of haemostatic agents, drawing benefits from such lower concentrations as they limit unwanted side effects of the haemostatic agents. Preferred compositions utilize Poly(N-vinylpyrrolidone), Poly(2-ethyl-2-oxazoline) as thickening agents and ferric sulfate as an active ingredient.Type: ApplicationFiled: August 6, 2007Publication date: February 12, 2009Applicant: CAO GROUP, INC.Inventor: Steven D. Jensen
-
Publication number: 20080260864Abstract: The present invention relates to topical compositions comprising as active ingredients Aluminium Chloride and Sulfur for treatment of skin irritation induced by depilation. Said compositions have pharmaceutical and/or cosmetic and/or quasi cosmetic properties. The present invention also involves methods of making and methods of using such compositions. Furthermore, the present invention consists of a method for prevention and/or treatment of skin irritation induced by depilation.Type: ApplicationFiled: October 18, 2006Publication date: October 23, 2008Applicant: MEDIDERMIS LTD.Inventor: Avi Dascalu
-
Patent number: 7049339Abstract: A composition for treating a disease affecting the hoof of an animal comprising an active ingredient and a colloid former is described. The active ingredient may comprise zinc sulphate, copper sulphate, an organic acid, an alkali metal salt or a mixture thereof. The composition as disclosed has the advantage that it is more effective at applying an active ingredient to a hoof than a conventional, non-colloid system.Type: GrantFiled: June 14, 2002Date of Patent: May 23, 2006Assignee: Forty Eight Shelf (80) LimitedInventor: William Thomson
-
Patent number: 7029705Abstract: A method is disclosed of practicing nasal hygiene comprising the steps of applying to a person's nostril a non-irritating hygienic composition consisting essentially of a product of compounding under homogenizing conditions water, 0.01% to 5% by weight, as chlorine dioxide, of a source of chlorine dioxide; 0.01% to 3% by weight of at least one olfactory stimulant, 0 to 5% by weight of at least one fixative compound less volatile than the olfactory stimulant 0.1 to 2.5% by weight of at least one inorganic salt selected from the group consisting of alkali metal chloride, alkali metal bicarbonate, and alkali metal chlorate; and 0.0002 to 0.006% (as aluminum) by weight of at least one water soluble aluminum compound, provided that the total concentration of inorganic salt is in the range from 0.6% by weight to 2.5% by weight, holding the composition within the nostril for a hygienic holding period, and discharging the composition from the treated nostril.Type: GrantFiled: July 30, 2003Date of Patent: April 18, 2006Inventor: Allan H. Fuhr
-
Patent number: 7011824Abstract: A method of treating animal manure solids comprises contacting the solids with a treatment composition comprising AlCl3.nH2O or Al(NO3)3.mH2O, or the residue of AlCl3.nH2O or Al(NO3)3.mH2O, to form a treated waste product, wherein n is from 0 to 10, and m is from 0 to 12. The treatment amount can be effective to reduce phosphorus solubility in the manure; reduce phosphorus runoff and/or phosphorus leaching from fields fertilized with manure; inhibit ammonia volatilization from the manure; flocculate solids in the manure; reduce pathogens in the manure; increase the nitrogen content in the manure; and/or reduce acid rain and PM-10s associated with the manure.Type: GrantFiled: December 4, 2000Date of Patent: March 14, 2006Assignees: The United States of America as represented by the Secretary of Agriculture, The Board of Trustees of the University of ArkansasInventor: Philip A. Moore, Jr.
-
Patent number: 6958159Abstract: The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin.Type: GrantFiled: March 26, 2001Date of Patent: October 25, 2005Assignee: Chiltern Pharmaceuticals, Pty Ltd.Inventor: Robert Alan Smith
-
Publication number: 20040253321Abstract: The invention relates to an anti-inflammatory, wound-healing glass powder, whereby the glass of the glass powder comprises the following components: 20-80 wt. % SiO2, 0-40 wt. % Na2O, 0-40 wt. % K2O, 0-40 wt. % Li2O, 0-40 wt. % CaO, 0-40 wt. % MgO, 0-40 wt. % Al2O3, 0-1 wt. % P2O5, 0-40 wt. % B2O3 and 0-10 wt. % ZnO.Type: ApplicationFiled: March 24, 2004Publication date: December 16, 2004Inventors: Jorg Hinrich Fechner, Jose Zimmer
-
Patent number: 6814984Abstract: The present invention is directed to frozen biocidal compositions. Specifically, the biocidal compositions comprise a frozen aqueous solution of a plurality of ions selected from the group consisting of halide and oxyhalide ions. The frozen biocidal compositions are useful in preserving or extending the shelf-life of perishable articles.Type: GrantFiled: February 8, 2002Date of Patent: November 9, 2004Assignee: Clean Water International LLCInventors: David C. Rose, Lawrence J. Ventura
-
Patent number: 6797260Abstract: A composition is disclosed which has been shown to stop or control bleeding and seal open small blood vessels while accelerating the healing process of abraded oral “gum” and other “skin” (epithelial) tissues. The composition is preferably in the form of a paste which promotes ease of application and use of the composition. A variety of instruments can be used in application and cleanup of the composition showing versatile unparalleled friendly usage. The composition preferably comprises aluminum chloride, ferric sulfate (subsulfate), regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and a solvent. The composition has many dental and medical procedure applications.Type: GrantFiled: September 18, 2003Date of Patent: September 28, 2004Inventor: Terence Prevendar
-
Publication number: 20040175433Abstract: A composition for treating a disease affecting the hoof of an animal comprising an active ingredient and a colloid former is described. The active ingredient may comprise zinc sulphate, copper sulphate, an organic acid, an alkali metal salt or a mixture thereof. The composition as disclosed has the advantage that it is more effective at applying an active ingredient to a hoof than a conventional, non-colloid system.Type: ApplicationFiled: December 12, 2003Publication date: September 9, 2004Inventor: William Thomson
-
Publication number: 20040131696Abstract: A method for treating skin itch in an individual in need of such treatment, by topically administering an amount effective for relieving said itch of an additive selected from the group consisting of (a) aluminum chlorohydrates; (b) aluminum zirconium chlorohydrates; (c) chlorohydrates of aluminum and aluminum zirconium, each complexed with polyalkylene glycol; (d) chlorohydrates of aluminum and aluminum zirconium, wherein in each of said chlorohydrates some of the water of hydration has been replaced by glycine; (e) aluminum chloride hydrate; and mixtures thereof. In particular, a spray comprising aluminum chlorohydrate aqueous composition is applied to the affected surface area of the skin to effect relief from itching.Type: ApplicationFiled: January 6, 2003Publication date: July 8, 2004Inventor: Gilbert Buchalter
-
Patent number: 6692775Abstract: A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The bactericidal liquid concentrate in the amount of 3.5 to 12 ml in one liter of gel formulation is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: June 24, 2002Date of Patent: February 17, 2004Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Patent number: 6689392Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.Type: GrantFiled: January 29, 2002Date of Patent: February 10, 2004Assignee: Agricare Ltd.Inventor: Ran Lifshitz
-
Patent number: 6652840Abstract: A composition is disclosed which has been shown to stop or control bleeding and seal open small blood vessels while accelerating the healing process of abraded oral “gum” and other “skin” (epithelial) tissues. The composition is preferably in the form of a paste which promotes ease of application and use of the composition. A variety of instruments can be used in application and cleanup of the composition showing versatile unparalleled friendly usage. The composition preferably comprises aluminum chloride, ferric sulfate (subsulfate), regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and a solvent. The composition has many dental and medical procedure applications.Type: GrantFiled: February 8, 2002Date of Patent: November 25, 2003Inventor: Terence Prevendar
-
Patent number: 6641825Abstract: A gentle skin cleansing gel is provided containing as an ingredient, water soluble salts having a negative enthalpy in solution, which when mixed with water release heat which improves the cleansing effect and the release of perfumes creating a pleasant effect on the skin.Type: GrantFiled: August 30, 2002Date of Patent: November 4, 2003Assignee: Henkel Kommanditgesellschaft auf AktienInventors: Wolfhard Scholz, Katrin Meyer zu Schlochtern-Maric, Armin Wadle
-
Patent number: 6541038Abstract: A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/or lignin derivatives in the wood to fix the metal component in the wood, and wood and woody materials obtained by the treating method. According to the method of the present invention, while effectively utilizing lignins, lignosulfonic acids, or lignosulfonic acid salts, leaching of the metal component can be suppressed to a low level to thereby retain the effects due to the incorporation of the metal components for a prolonged period.Type: GrantFiled: May 25, 2000Date of Patent: April 1, 2003Assignee: SDS Biotech K.K.Inventors: Keijitsu Tanaka, Hirobumi Aoki, Takashi Echigo
-
Patent number: 6517819Abstract: An antiperspirant suspension which is finely divided, which is contained in a non-aqueous phase, and which has improved efficacy for perspiration reduction when used on human skin, includes at least one basic aluminum-zirconium-halogenohydrate complex as active ingredient in which at least 60% of the zirconium content can be directly titrated after dissolving in 0.1 n HCl with EDTA at a pH of 0.8, wherein the active ingredient optionally contains an amino acid. A process for the synthesis of the antiperspirant suspension includes mixing an aluminum salt which is effective as an antiperspirant with a zirconium salt which is effective as an antiperspirant, optionally in the presence of an amino acid, in a non-aqueous oil phase in the absence of water to provide a mixture; and grinding the mixture.Type: GrantFiled: May 26, 2000Date of Patent: February 11, 2003Assignee: BK Giulini Chemie GmbH und Co OhgInventors: Johannes Breker, Bruno Kaufmann, Wolfgang Reibel, Klaus Schanz
-
Patent number: 6428778Abstract: A process for synthesis of finely divided antiperspirant suspensions includes providing an antiperspirant salt consisting essentially of an Al salt which is effective as an antiperspirant and which is described by an empirical formula as follows: Al(OH)(3−b)XbzH2O where b=0.4 to 3, z<4, and X=halogen; mixing the Al salt into a non-aqueous oil phase to provide a mixture; and subsequently grinding the mixture with a suitable milling device at a temperature below 80° C. to provide a suspension having a preselected fineness. A perspiration-inhibiting cosmetic preparation includes, as active ingredient, the antiperspirant suspension described above.Type: GrantFiled: May 26, 2000Date of Patent: August 6, 2002Assignee: BK Guilini Chemie GmbH und Co OHGInventors: Johannes Breker, Bruno Kaufmann, Wolfgang Reibel, Klaus Schanz
-
Patent number: 6416790Abstract: The concentrate is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 microhmo to about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The liquid concentrate is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: March 13, 2000Date of Patent: July 9, 2002Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Patent number: 6352706Abstract: An ingestible mollusc poison contains a simple metal compound, an activity enhancing additive such as ethylene diamine disuccinic acid (EDDS) and derivatives thereof, and a carrier material edible to molluscs. In one embodiment the active agent of the mollusc poison may be in the form of a metal complex of EDDS. The composition may be used alone or in conjunction with molluscicidal co-active agents and/or fertilizers.Type: GrantFiled: February 1, 1999Date of Patent: March 5, 2002Assignee: W. Neudorff GmbH KGInventor: George S. Puritch
-
Patent number: 6350474Abstract: The invention deals with phosphate water solution with cold solidification capacity. Phosphate composition containing iron oxide solution in acid, water, advantages from the following properties; it contains orthophosphorus acid and in addition metal powder. Phosphate composition is ecologically pure product, non toxic, non cancerogenic, non-allergic. It has antimicrobial, antivirus and fungicidal properties. Phosphate composition can be applied within medicine: surgery, dermatology, dentistry, oncology, pharmacology and other branches. In agriculture use: as a means of curing plant diseases, within veterinary—as a means for preventive maintenance and curing of animal diseases, within construction—as an anticorrosive, fire-resistant, hydro-electric isolating covers, ceramic tiles, concretes, which protect against radiation, as well as for producing other composite materials.Type: GrantFiled: June 7, 1999Date of Patent: February 26, 2002Inventors: David Dzneladze, Andro Dzneladze, Nargisa Jabishvili
-
Patent number: 6346240Abstract: A method of treating liquid animal manure comprising contacting a manure slurry with a treatment composition comprising a treatment effective amount of AlCl3.nH2O or Al(NO3)3.mH2O, or the residue of AlCl3.nH2O or Al(NO3)3.mH2O, to form a resulting slurry, wherein n is from 0 to 10, and m is from 0 to 12. The treatment effective amount is effective to reduce phosphorus solubility in the manure; reduce phosphorus runoff and/or phosphorus leaching from fields fertilized with manure; inhibit ammonia volatilization from the manure; flocculate solids in the manure; reduce pathogens in the manure; increase the nitrogen content in the manure; and/or reduce acid rain and PM-10s associated with the manure.Type: GrantFiled: October 22, 1998Date of Patent: February 12, 2002Assignees: The United States of America as represented by the Secretary of Agriculture, The Board of Trustees of the University of ArkansasInventor: Philip A. Moore, Jr.
-
Patent number: 5935608Abstract: An antibacterial titania comprising a titania to which ions of an antibacterial metal are adhered, wherein the antibacterial metal is silver; and the antibacterial titania further contains chlorine at a Cl/Ag molar ratio in a range of from 2.8 to 7.2. A process for producing an antibacterial titania which comprises the steps of: (1) incorporating a salt of an antibacterial metal into a slurry of metatitanic acid to adhere ions of the antibacterial metal to titania in the metatitanic acid slurry; and (2) adding a source of chlorine ions to the slurry, wherein the antibacterial metal is silver.Type: GrantFiled: April 15, 1997Date of Patent: August 10, 1999Assignee: Nittetsu Mining Co., Ltd.Inventors: Hideki Fujikawa, Katsuyuki Tanabe
-
Patent number: 5914135Abstract: Calcium carbonate liquid antacid compositions containing one or more pH adjusting agents to maintain the pH above 9.0, preferably above 9.5. The resultant antacid liquid possesses superior resistance to microbial attack and enhanced taste properties.Type: GrantFiled: April 16, 1997Date of Patent: June 22, 1999Assignee: McNeil-PPC, Inc.Inventors: John J. Dubek, Gerard P. McNally, Bruce P. Smith
-
Patent number: 5874065Abstract: The invention describes an oral anti-acid paste comprising anti-acid compound in a slow releasing carrier medium which disperses the anti-acid, and releases the anti-acid from the paste upon contact with the aqueous media such as saliva. The paste can be used by placement in the mouth for slow release of the anti-acid into the saliva thereby contacting the mucosa of the esophagus to inhibit irritation to the mucosa due to excess acid.Type: GrantFiled: June 26, 1997Date of Patent: February 23, 1999Inventor: Alan A. Pardini
-
Patent number: 5820822Abstract: An antimicrobial and deodorizing composition is disclosed, which includes an aqueous solution having at least one acid-inducing metal salt and a metal chlorite and no protic acid. The aqueous solution has a pH less than about 7. The acidity-inducing metal salt, preferably, includes a iron cation, an aluminum cation, a gadolinium cation, a vanadium cation, a zirconium cation or a zinc cation, and anions sufficient for rendering said metal salt electrically neutral and water-soluble. The metal chlorite may, preferably, be sodium chlorite. Various methods for use of the composition are also disclosed.Type: GrantFiled: October 25, 1996Date of Patent: October 13, 1998Inventor: Robert D. Kross
-
Patent number: 5750150Abstract: Injectable compositions for treating affected tissues are prepared by formulating sodium hydrogen sulfite with all other components except tannic acid to yield a first mixture and adding tannic acid to the first mixture, or, by formulating a water-soluble aluminum compound and a chelating agent to yield a first formulation, formulating tannic acid and sodium hydrogen sulfite to yield a second formulation and admixing the first formulation with the second formulation to yield a second mixture and, as needed, adding a polyvalent alcohol and/or a saccharide to the first and/or second formulations or to the first or second mixture, thereby formulating the injectable composition having a pH range of from pH 1.0 to pH 3.5. This preparation can prevent the oxidation of tannic acid and the direct reaction with aluminum ions derived from sodium hydrogen sulfite, whereby the composition can provide a stable formulation as well as ensure effectiveness as an injectable preparation in a solution form.Type: GrantFiled: May 28, 1996Date of Patent: May 12, 1998Assignee: Traditional Chinese Medicine Research Laboratory, Inc.Inventors: Hideo Okazaki, Kinuko Oku
-
Patent number: 5667790Abstract: A method of treating skin affected by acne or rosacea includes the steps of applying to affected skin a composition containing up to 50% by weight aluminum halide salt in a liquid carrier, allowing the composition to remain on the affected skin for an extended period of time which exceeds ten minutes, and washing off the composition. The composition is preferably applied to affected skin just prior to bedtime and is allowed to remain on the skin while the patient sleeps. Alternatively, liquid make-up compositions containing up to 50% by weight aluminum halide salt are applied as a part of a daily make-up routine and allowed to remain on affected skin all day long. The methods of treatment provide an improved treatment of acne and rosacea.Type: GrantFiled: August 14, 1995Date of Patent: September 16, 1997Inventor: Billy B. Sellers, Jr.
-
Patent number: 5460835Abstract: A method for stimulating the formation of new mammalian bone, which entails administering an effective amount of one or more water-soluble aluminum salts to a mammal.Type: GrantFiled: August 16, 1993Date of Patent: October 24, 1995Assignee: Duke UniversityInventors: Marc Drezner, L. Darryl Quarles
-
Patent number: 5455050Abstract: The present invention relates to an aqueous pharmaceutical suspension for oral use, and a method of preparation, having antacid and antiulcer properties which contains a therapeutically effective amount of calcium carbonate in combination with magnesium carbonate and/or magnesium trisilicate and a carboxylic acid pH adjusting agent.Type: GrantFiled: November 12, 1993Date of Patent: October 3, 1995Assignee: McNeil-PPC, Inc.Inventors: Douglas S. Beyerle, Gerard P. McNally
-
Patent number: 5411731Abstract: A bath additive composition comprises an aluminum salt and a carbonate and makes the pH of bath water 8 or higher but less than 9 when the bath additive composition is dissolved in the bath water. The bath additive composition does not damage bathtubs, bath water heating devices, or the skin of users, provides a refreshing feel to the skin after bathing, and has an excellent ability of suppressing perspiration.Type: GrantFiled: July 21, 1993Date of Patent: May 2, 1995Assignee: Kao CorporationInventors: Norihiro Tanaka, Kazuyuki Okui, Yasuhiro Doi, Hirotaka Sato, Hidenori Yorozu